RxDoctor Payments Data

William Strickland

Optometrist · Oxford, MSNPI 1093704223

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.6% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 25.8% of the total.

$2,938in general payments, 2019–2025

Across 70 payments — averaging $41.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$757
  • Coopervision Inc.$630
  • Alcon$464
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$259
  • Optos, Inc.$226
  • Glaukos Corporation$216
  • plus $386 from 6 others

What the payments were for

  • Food & beverage$2,69292%
  • Gifts$191%
  • Entertainment$2268%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,938 in reported general payments places this provider in the 85th percentile of 372 optometrist providers in Mississippi.

See all optometrist providers in Mississippi

Medicare billing

Part B allowed, 2024
$71,189
Medicare patients
307
Services billed
961

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost334$1,747
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat41$771
Brimonidine Tartrate25$206
Timolol Maleate25$192
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha13$139

Paid to pharmacies, not to this prescriber.

Other optometrist in Oxford

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →